The burden of skin disease and eye disease due to onchocerciasis in countries formerly under the african programme for onchocerciasis control mandate for 1990, 2020, and 2030

Background Onchocerciasis (“river blindness”) can cause severe morbidity, including vision loss and various skin manifestations, and is targeted for elimination using ivermectin mass drug administration (MDA). We calculated the number of people with O